Edgewise Therapeutics, Inc. (EWTX) Tops Q2 EPS by 1c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.34), $0.01 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• NPR retracts story about Justice Alito retiring from Supreme Court
• Increasing unusual put volume: SOLS NTR SHW CIA AVAV ABVX LTPH ARKG TTE OLN SOC CHYM VSH
• Lemonade cuts quota share cession to 18% in reinsurance renewal